KAPA Kairos Pharma Ltd Yalpi foyda marjasi

KAPA (Kairos Pharma Ltd) - kompaniyaning tovar belgisi

Kairos Pharma Ltd (KAPA) kompaniyasining yalpi foyda marjasi ximmioqarshilikka qarshi kurashayotgan tibbiyot markazlari bilan ittifoqlarning samaradorligini ko'rsatmoqda. Xarajatlarni optimallashtirish molekulalarning dastlabki sinovlarini tashqi laboratoriyalarga autsorsing qilish orqali amalga oshiriladi. O'pka va prostata saratoni immunoterapiyasining joriy etilishi bemorlarning yashab qolish darajasini oshiradi, 0.00 esa ushbu ko'rsatkich darajasining yakuniy belgisi bo'lib xizmat qiladi.

KAPA Kairos Pharma Inc Yalpi foyda bo'yicha rentabellik (17.09.2024 - 20.11.2026)

Kairos Pharma Inc (KAPA) moliyaviy va bozor koʻrsatkichlari kesimi

Fundamental baholash:Kairos Pharma Ltd
Kairos Pharma Limited tovar namunasi

Professional aktivlarni tanlash ishlab chiqarish xarajatlarining beqarorligi sharoitida biznesning ortiqcha pul oqimini yaratish qobiliyatiga asoslanadi. Valo profit marginini tahlil qilish orqali investor bevosita xarajatlar chegirib tashlanganidan keyin qolgan daromad qismini baholaydi, bu esa Kairos Pharma Ltd (KAPA) kompaniyasi yuqori malakali tibbiy xodimlar tomonidan qo'llab-quvvatlanadigan klinik sinovlar tarmog'ini kengaytirayotgan bir paytda samarali xarajatlar boshqaruvini tasdiqlaydi.

Asosiy raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Yalpi rentabellik|TuHURA Biosciences Inc. - Yalpi marja|TARA - Yalpi marja|FATE (Fate Therapeutics) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Aadi Bioscience, Inc.|Yalpi foyda bo'yicha rentabellik TCRX|Yalpi rentabellik CSBR|Yalpi marja XBIT|Yalpi foyda bo'yicha sotuv rentabelligi CEL-SCI Corp.|Yalpi rentabellik ostherapies.com OSTX|RADX: Sotuvning yalpi rentabelligi|ARTV: Yalpi foyda bo'yicha rentabellik|ANL (Adlai Nortye) - Sotuvning yalpi rentabelligi|Veru (VERU) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Tempest Therapeutics Inc|Yalpi rentabellik Xilio Therapeutics|Sotuvning yalpi rentabelligi RENB (Renovaro Inc.)|Yalpi rentabellik Mural Oncology PLC (MURA)|Yalpi foyda bo'yicha sotuv rentabelligi OnKure Therapeutics, Inc.|Yalpi marja GDTC (w2.cytomed.sg)|CRIS - Yalpi foyda bo'yicha rentabellik|Apollomics - Yalpi marja|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik